Keywords: b-ms, taxol, wins, fda, ok, early, breast

B-MS' Taxol wins FDA OK for early breast cancer

Article | 28 October 1999

• Print This

Bristol-Myers Squibb's Taxol (paclitaxel) has been backed by the USregulatory authority for treating early-stage breast cancer which has spread no ...

Enjoying this article? To continue reading you need to login or subscribe.